Company
CTTH · CIK 0001035422
Purchase of 10,100 shares at $0.045 per share.
Reporting Person CTT PHARMACEUTICAL HOLDINGS, INC. · Officer Title CEO · Transaction Code P
Traded Sep 22, 2026 · Disclosed Sep 22, 2026
Source: SEC Form 4 · 0001035422-26-000013 · filed 2026-09-22 · View filing →
Purchase of 10,900 shares at $0.048 per share.
Reporting Person CTT PHARMACEUTICAL HOLDINGS, INC. · Officer Title CEO · Transaction Code P
Traded Sep 16, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001035422-26-000012 · filed 2026-09-16 · View filing →
Purchase of 3,500 shares at $0.05 per share.
Reporting Person CTT PHARMACEUTICAL HOLDINGS, INC. · Officer Title CEO · Transaction Code P
Traded Sep 10, 2026 · Disclosed Sep 10, 2026
Source: SEC Form 4 · 0001035422-26-000011 · filed 2026-09-10 · View filing →
Purchase of 9,800 shares at $0.0489 per share.
Reporting Person CTT PHARMACEUTICAL HOLDINGS, INC. · Officer Title CEO · Transaction Code P
Traded Sep 4, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001035422-26-000010 · filed 2026-09-04 · View filing →
Purchase of 3,000 shares at $0.0489 per share.
Reporting Person CTT PHARMACEUTICAL HOLDINGS, INC. · Officer Title CEO · Transaction Code P
Traded Sep 2, 2026 · Disclosed Sep 2, 2026
Source: SEC Form 4 · 0001035422-26-000009 · filed 2026-09-02 · View filing →
Purchase of 3,500 shares at $0.049 per share.
Reporting Person CTT PHARMACEUTICAL HOLDINGS, INC. · Officer Title CEO · Transaction Code P
Traded Aug 31, 2026 · Disclosed Aug 31, 2026
Source: SEC Form 4 · 0001035422-26-000008 · filed 2026-08-31 · View filing →
Purchase of 2,100 shares at $0.055 per share.
Reporting Person CTT PHARMACEUTICAL HOLDINGS, INC. · Officer Title CEO · Transaction Code P
Traded Aug 24, 2026 · Disclosed Aug 24, 2026
Source: SEC Form 4 · 0001035422-26-000007 · filed 2026-08-24 · View filing →
Purchase of 11,500 shares at $0.045 per share.
Reporting Person CTT PHARMACEUTICAL HOLDINGS, INC. · Officer Title CEO · Transaction Code P
Traded Aug 20, 2026 · Disclosed Aug 20, 2026
Source: SEC Form 4 · 0001035422-26-000006 · filed 2026-08-20 · View filing →
Purchase of 10,000 shares at $0.059 per share.
Reporting Person CTT PHARMACEUTICAL HOLDINGS, INC. · Officer Title CEO · Transaction Code P
Traded Aug 19, 2026 · Disclosed Aug 19, 2026
Source: SEC Form 4 · 0001035422-26-000005 · filed 2026-08-19 · View filing →
Purchase of 1,800 shares at $0.062 per share.
Reporting Person CTT PHARMACEUTICAL HOLDINGS, INC. · Officer Title CEO · Transaction Code P
Traded Aug 14, 2026 · Disclosed Aug 14, 2026
Source: SEC Form 4 · 0001035422-26-000004 · filed 2026-08-14 · View filing →